With the Allergan acquisition, we are bringing together more than 30 brands and leadership positions to expand and diversify our product portfolio.  This allows us to have immediate scale and profitability to advance our innovative science pipeline that brings patients groundbreaking medicines across a wide spectrum of therapeutic need/critical therapeutic areas.

We continue to build a sustainable company for the long term that provides profitable growth for shareholders, financial flexibility to invest and expand our reach to help address the needs of people and communities around the world. 

Advancing our mission

Learn how the acquisition of Allergan allows us to better serve patients today and invest in the medicines of the future.